Day: September 2, 2021

Medical Drone Market to Hit $1,410.9 Mn Forecast [2021-2028]; Increased Demand for Contactless Devices to Bode Well for This Industry, Report by Fortune Business Insights™

Medical Drone Market to Hit $1,410.9 Mn Forecast [2021-2028]; Increased Demand for Contactless Devices to Bode Well for This Industry, Report by Fortune Business Insights™

Key players covered in the medical drone market are Zipline Inc. (San Francisco, United States), Volocopter GmbH (Bruchsal, Germany), Volansi Inc. (San Francisco, United States), Matternet Inc. (Mountain View, United States), Manna Drone Delivery Inc. (Dublin, Ireland) , Flytrex Aviation Ltd. (Tel Aviv, Israel), Flirtey Holdings Inc. (Reno, United States), Vayu Inc. (Ypsilanti, United States), Skyports Ltd. (Billericay, United Kingdom), Ebre Drone LLC (Tarragona, Spain), Swoop Aero Pty. Ltd. (Docklands, Australia), Skyfarer Ltd. (Coventry, United Kingdom), and more players profiled Pune, India, Sept. 02, 2021 (GLOBE NEWSWIRE) — The global medical drone market size is expected to gain momentum by reaching USD 1,410.9 million by 2028 from USD 254.7 million in 2021 while exhibiting an impressive CAGR of 27.70% between  2021 to 2028....

Continue reading

Supernus Announces Qelbree™ sNDA for Adult Indication Accepted for Review by FDA

Supernus Announces Qelbree™ sNDA for Adult Indication Accepted for Review by FDA

ROCKVILLE, Md., Sept. 02, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the U.S. Food and Drug Administration (FDA) has acknowledged it has received the supplemental new drug application (sNDA) for Qelbree (viloxazine extended-release capsules) for the treatment of attention-deficit hyperactivity disorder (ADHD) in adult patients. The sNDA is now considered filed, with a user fee goal date (PDUFA date) of April 29, 2022. In December 2020, Supernus announced positive topline results from a Phase III study of Qelbree in adults for the treatment of attention deficit hyperactivity disorder (ADHD). The results showed that at a daily dose of up to 600mg,...

Continue reading

CytoDyn to Hold Webcast on September 8 to Discuss Results from mTNBC Trials, HIV BLA Status, and Updates on COVID-19 and NASH Trials

CytoDyn to Hold Webcast on September 8 to Discuss Results from mTNBC Trials, HIV BLA Status, and Updates on COVID-19 and NASH Trials

VANCOUVER, Washington, Sept. 02, 2021 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, and Christopher Recknor, M.D., Chief Operating Officer and Head of Clinical Development, will host an investment community webcast on Wednesday, September 8, 2021. Management will provide an overview of the results from the recently reported data from the mTNBC trials, along with updates on COVID-19 and NASH trials, and the status of the resubmission of the BLA for HIV. Management will provide approximately 60 minutes...

Continue reading

Sabre Gold Completes Acquisition of Golden Predator

Sabre Gold Completes Acquisition of Golden Predator

TORONTO, Sept. 02, 2021 (GLOBE NEWSWIRE) — Sabre Gold Mines Corp. (formerly Arizona Gold Corp.) (“Sabre Gold” or the “Company”) (TSX: AZG, OTCQB: AGAUF) and Golden Predator Mining Corp. (“Golden Predator”) (TSX.V: GPY, OTCQX: NTGSF) are pleased to announce the successful completion of the previously-announced business combination, pursuant to which Sabre Gold has acquired all of the issued and outstanding common shares of Golden Predator (the “Golden Shares”) by way of a statutory plan of arrangement under the provisions of the Business Corporations Act (British Columbia) (the “Arrangement”). With the Arrangement now complete, Sabre Gold intends to cause the Golden Shares to be delisted from the TSX Venture Exchange (expected on or about close of markets on September 3, 2021), and Golden Predator intends to submit an application...

Continue reading

Sabre Gold Completes Acquisition of Golden Predator

Sabre Gold Completes Acquisition of Golden Predator

TORONTO, Sept. 02, 2021 (GLOBE NEWSWIRE) — Sabre Gold Mines Corp. (formerly Arizona Gold Corp.) (“Sabre Gold” or the “Company”) (TSX: AZG, OTCQB: AGAUF) and Golden Predator Mining Corp. (“Golden Predator”) (TSX.V: GPY, OTCQX: NTGSF) are pleased to announce the successful completion of the previously-announced business combination, pursuant to which Sabre Gold has acquired all of the issued and outstanding common shares of Golden Predator (the “Golden Shares”) by way of a statutory plan of arrangement under the provisions of the Business Corporations Act (British Columbia) (the “Arrangement”). With the Arrangement now complete, Sabre Gold intends to cause the Golden Shares to be delisted from the TSX Venture Exchange (expected on or about close of markets on September 3, 2021), and Golden Predator intends to submit an application...

Continue reading

Dentsply Sirona to Present at the Baird 2021 Global Healthcare Conference on September 15th

Dentsply Sirona to Present at the Baird 2021 Global Healthcare Conference on September 15th

CHARLOTTE, N.C., Sept. 02, 2021 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), The Dental Solutions Company, today announced it will participate in the Baird 2021 Global Healthcare Conference. Jorge Gomez, Chief Financial Officer, will represent the company. He is scheduled to participate in a fireside chat on September 15th, 2:35PM Eastern Time. Investors and other interested parties will be able to access a live webcast by visiting the Investor section of the Dentsply Sirona website: https://investor.dentsplysirona.com. A replay will also be available for a period of time on the Investor section of the Dentsply Sirona website at https://investor.dentsplysirona.com. About Dentsply Sirona Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 134-year...

Continue reading

ExGen Announces Sulphide zone assays 8.38% over 0.5m

ExGen Announces Sulphide zone assays 8.38% over 0.5m

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 02, 2021 (GLOBE NEWSWIRE) — ExGen Resources Inc. (TSX.V: EXG; OTC: BXXRF) (“ExGen”, the “Company”) is pleased to report that Phoenix Copper Ltd. (the Operator of the Empire Mine Project, “Phoenix”) has reported the first analytical results from the 2021 Deep Sulphide core drilling program, under the oxide open pit, at the Empire Mine in Idaho, USA (‘Empire’). ExGen owns 20% and Phoenix owns 80% of Konnex Resources, Inc. (“Konnex”), which holds the leases and claims to the Empire Mine Project. ExGen further has a 2.5% NSR royalty on the Empire Mine Project and owns 1,330,000 common shares of Phoenix. Program Highlights • Assay results from the first Hole KXD21-02 intercepts high-grade mineralisation...

Continue reading

Kuuhubb Inc. Announces Debt Restructuring of Subsidiary Kuu Hubb Oy

Kuuhubb Inc. Announces Debt Restructuring of Subsidiary Kuu Hubb Oy

The Debt Restructuring initiative focused specifically on its Finnish subsidiary Kuu Hubb Oy is intended to improve the company’s financial situation by decreasing its current debt burden HIGHLIGHTS: Board of Directors unanimously supports the debt restructuring of its Finland-based subsidiary Kuu Hubb Oy, which represents over €7.7 million of aggregate indebtedness Kuuhubb Inc.’s operations will continue without interruption; the process is not expected to have any impact on customers, vendors or employees The Debt Restructuring proceedings will be under the jurisdiction of the District Court of Helsinki, in Finland, governed by the Finnish Restructuring of Enterprises Act (47/1993, ”REA”) Following the debt restructuring process, the Company expects to emerge in a stronger financial situation, positioned for future growth TORONTO,...

Continue reading

TanGold to Attend and Present at 2021 Precious Metals Summit Beaver Creek Conference

TanGold to Attend and Present at 2021 Precious Metals Summit Beaver Creek Conference

TORONTO, Sept. 02, 2021 (GLOBE NEWSWIRE) — Tanzanian Gold Corporation (TSX:TNX) (NYSE American:TRX) (TanGold or the Company) announces that management will be attending and presenting at the Precious Metals Summit Beaver Creek conference taking place September 8-11, 2021. Management will be meeting one-on-one with conference attendees to provide an update on the oxide plant expansion, sulphide development progress, and recent exploration activities at the Company’s Buckreef Project. Precious Metals Summit brings together the community of institutional investors and corporate executives from senior precious metals companies to meet and network with some of the most prospective producers, explorers, and developers from around the globe.  TanGold’s CEO, Stephen Mullowney, will present Thursday, September 9 at 16:15 MDT. Please...

Continue reading

Sigma Lithium Announces Selection of NASDAQ as Its U.S. Market for Its Dual-Listing, Participation at United Nations High Level Dialogue on Energy Transition and Provides Pre-Construction Update Following Release of 2Q21 Results

Sigma Lithium Announces Selection of NASDAQ as Its U.S. Market for Its Dual-Listing, Participation at United Nations High Level Dialogue on Energy Transition and Provides Pre-Construction Update Following Release of 2Q21 Results

INVESTOR VIDEO CONFERENCE CALLSeptember 8, 2021 at 11:00 AM (EST) Zoom video call registration link:https://us06web.zoom.us/webinar/register/WN_b6lO9Yo3TjOlQT9XtJRx1g Zoom ID:865 1276 0999 Join by phone using the following dial in:North America: +1 646 558 8656, UK: +44 203 481 5237, Brazil: +55 11 4680 6788 SUMMARY Sigma Lithium to join NASDAQ Company to present at United Nations High-Level Dialogue for Energy 2021 Transition Conference on Sept. 24 in New York Company on target to begin production in 2022 and achieve net zero carbon emissions ahead of the targets announced by the United Nations for the Decade of Action Against Climate Change Investor call set for Sept. 8 at 11 a.m. EST VANCOUVER, British Columbia, Sept. 02, 2021 (GLOBE NEWSWIRE) — SIGMA Lithium Corporation (“Sigma” or the “Company”) ( TSX-V:...

Continue reading